Practiceby Lab 10 Get started ›
Crossfire

Should I take creatine after menopause?

What the experts say

Stacy T. SimsPhD · exercise physiologist and nutrition scientist

Yes, daily

What it rests onThe 2023 International Society of Sports Nutrition position stand on the female athlete, which she first-authored, plus subsequent reviews she reads as supporting cognitive and mood benefit.

Source: pubmed.ncbi.nlm.nih.gov ↗
Jennifer GunterMD · OB/GYN and pain medicine physician

Not by default, and not for bone

What it rests onLong-duration randomised trials in postmenopausal women with bone density and lean mass as primary endpoints, read as outcome data rather than mechanism.

Source: vajenda.substack.com ↗
Mary Claire HaverMD, FACOG, MSCP · OB/GYN and menopause specialist

Yes, 5 g a day

What it rests onPresented as part of a practice-derived stack rather than argued from named trials; the post cites no study for the creatine item specifically.

Source: drmaryclairehaver.substack.com ↗

Overview

Three answers with three different kinds of reasoning behind them, aimed at overlapping but different readers. Sims writes for women who already train deliberately, and her strongest evidence is for strength and lean mass in people doing resistance work, which is a claim Gunter does not contest.

Gunter writes for the general menopausal population reading a supplement recommendation, and her objection is scoped to the two endpoints that market uses to sell it: bone density and cognition. Haver arrives differently again, listing the dose in a stack without naming a study for it, which puts her close to Sims on the answer and apart from both on the reasoning, and she is the only one of the three who sells creatine.

The live disagreement is not whether creatine works for strength in people who train. It is whether that is enough to make it a default recommendation for every woman in menopause.

Where they agree

All three hold that resistance training is the intervention that matters and that creatine is at most an addition to it; Haver says in the same post that supplements do not replace behaviour.

None of them disputes that creatine monohydrate is cheap, safe for most people, and supported for strength in trained populations. Sims and Gunter both tell readers to buy only third-party tested product and name overlapping certification marks: Sims names CreaPure, NSF and Informed Sport, Gunter names NSF, USP, Informed Choice and the Banned Substances Control Group. Neither Sims nor Gunter has a disclosed financial relationship with a creatine brand.

What would settle it

A trial in postmenopausal women powered for bone density and for a defined cognitive endpoint, with resistance training controlled rather than optional, running long enough to see bone remodelling. Gunter already rests on two-year data with those endpoints, so a positive result would move her further than a mechanistic finding would.

Sims's cognitive extension rests on shorter studies with softer endpoints and would move first. Haver would move fastest of the three, because her position rests on practice pattern rather than on a reading of the evidence, and a clear null would leave it with nothing to stand on.

Practice does not pick a winner here

You do, and your call is dated, kept, and yours to change. Follow the people you already trust and what they publish turns into a short daily practice.

Get started

Free to sign up and use. We do not ask for a card.